On-Demand Fireside Chat

Formulation and Delivery
of Spray Dried Biologics
for Pulmonary Dosage Forms.

Speakers:

Dr. Richard Johnson

Chief Scientific Officer

Dr Richard Johnson is the Founding Director and Chief Scientific Officer at Upperton Pharma Solutions, a UK-based Contract, Development and Manufacturing Organisation (CDMO) and graduated from Warwick University with a PhD Biochemistry. In 1994 he was part of a management buy-out team that founded Andaris Ltd, a research and development company exploiting the use of spray drying technology in the fields of diagnostic imaging and drug delivery. In 1999, Dr Johnson founded Upperton and has overseen significant growth and expansion over the past 25 years, specialising in spray drying and nasal drug development.

Shailesh Mistry

Shailesh Mistry

Development Manager

Shailesh is an experienced pharmaceutical scientist specialising in drug formulation and delivery systems focusing on orally inhaled and nasal drug products (OINDPs), spray drying, amorphous solid dispersions, and particle engineering. His expertise spans analytical chemistry, device technologies, and packaging solutions.

With over two decades in the industry, Shailesh has held senior roles at a variety of pharmaceutical companies building a strong foundation in analytical and inhalation sciences. Shailesh holds a BSc (Hons) in Medical Science from the University of Birmingham and is recognised for his technical leadership and problem-solving in pharmaceutical formulation. 

Let’s continue the conversation.
Set up a technical call with our experts below to learn more.

Download Our Fact Sheet: The New Rules of CDMO Partnerships

What Biotechs Should Be Looking For Next

Let's Talk.

Book a discovery call.

Speak with our team of experts and set up a discovery call to discuss your project in more detail.